EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS134-02826 
Organism
Homo sapiens 
Tissue/cell
Mesendoderm 
Coordinate
chr1:112946240-112947730 
Target genes
TF binding sites/motifs
Number: 8             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ATF3MA0605.2chr1:112947108-112947120AATGACGTCATC+6.52
ATF3MA0605.2chr1:112947108-112947120AATGACGTCATC-6.62
JDP2(var.2)MA0656.1chr1:112947108-112947120AATGACGTCATC-6.11
JDP2(var.2)MA0656.1chr1:112947108-112947120AATGACGTCATC+6.52
JUNMA0488.1chr1:112947109-112947122ATGACGTCATCAT-6.15
JUND(var.2)MA0492.1chr1:112947105-112947120ATCAATGACGTCATC+6.08
JUND(var.2)MA0492.1chr1:112947108-112947123AATGACGTCATCATC-6.36
RxraMA0512.2chr1:112946707-112946721AAGTTCAAAGGTTA+6.15
Number of super-enhancer constituents: 3             
IDCoordinateTissue/cell
SE_37744chr1:112944216-112948911HSMMtube
SE_38109chr1:112946043-112947972HUVEC
SE_45402chr1:112945200-112947213NHLF
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr1112946842112947264
chr1112947425112947481
Number: 1             
IDChromosomeStartEnd
GH01I112402chr1112944206112948554
Enhancer Sequence
AACCCATTTC TCAGTCATCA CAAGTTAAAG TTGTGACTTG ATTAAAACCT GTTAAAATTC 60
AGTGGAAGCA AAGGTATGCG TTTACCTGTA TGCTAAAGGC ACAAAAAACT AATCTAAGCA 120
GAAGGCTGGC CTTTTCTTTT CCCAAGTATT GTGCAGATAC AATTGGCTTG AACATGTCTC 180
TAAACTGACT TTCCCAGGAA CTGGCCAGGC CATCTCTTTC TTTTTGGTGC AGATCAACCT 240
GCCAGAAGTC AGAAGTAAAC TTGTTTTGGT TTGTAAATTA GACACGTGAA TGATAGACAA 300
TGATGACCCA TTGGAAAAGG AAAACTTCAT TATCCTTGCA GATGAAACCA AAAAGTATGC 360
TCTTTAAGGA TGAGAAATGA GAAGCTGACC AGTCACTAAC TCATTTAAAC CATGCAGCCT 420
CCTGTTACAG TATGTATTGT TATGTCCATT TTATAGCTAA AAAACTGAAG TTCAAAGGTT 480
AAATGGATGA AAGAGCAAGT GGCAGAGCCA GGATGCAAAC TCAGCTCTGT CAGATTCCAA 540
AATCCATGTG CTTTCCACTA TAACATACTG TCTCCCAGCA GAATTACTGT CCCTGAAGAA 600
CCATAGAACA ACAATTGCCA GGCTTGTTGT TGGAAATATT CAACTGATAC TCAATTGTTA 660
AATTTTTTTT AAGTCAGTTA TCTGTCTTAG AAGACAAAAC AACATCACGA GTTTTATTTC 720
TGCTAGAGGA TTATTTGAAG TTTTTTTTGC AGTTCAGATA AAGTCAGGTT ATGGGCATCG 780
CTAAAACACA GATTCCTTAA CTGTTTGATG GTTAATCCTT CATACCATAC TCTGGAGTTT 840
CTCCCCAGTG TGGAATCTTA GTGGAATCAA TGACGTCATC ATCCTACATT AGCATTTGAA 900
GGGTTTGCAT TCCAGGCTGC CTCTAGAATT GTGGCCCATG AATCATCTTA CTGAAAATAA 960
TCAATCTACA TGTTATTGTT CCCTTGTGGT ATTTTACAAG TTATGGTGGC ATTATTTCAG 1020
AAAAGCAAAA ATTTAGGGGA CTGATGGACA GATAGACAAT AGAGACGGTC AGATACATAT 1080
TTGATTGAAA TCATGTTACA ATTTCATTTA AATGAAATAA AGCCATCTAA CAAATTATAT 1140
AGAAATGATT CAGCCGGGTG CAGTGGCTCA CGCCTGTAAT TCCAGCACTT TGGGAGGCCG 1200
AGGTGGGCGG GTCACTTGAG GTCAGGAGTG CCAGACCAGC TTGACCAAAA TGGAGGAACC 1260
CCGTCTCTAC TAAAAATACA AAATTAGCCA GGCATGGTGG CACAAGCCTG TAATCCCAGC 1320
TACTTGGGAG TCTGAGGCAG GGGAATCTCT TGAACCAGGA GGCGGAGGTT GCGGTGAGGC 1380
CGAGGTTGCG GTGAGCCGAG GTTGCGCCAT TGCACTCCAG GCTGGGCAAC AAGAGCAAAA 1440
CTCCATCTCA AAAAAAACAA ACAAAAAAAA TGTAATGTTT CAGTTTCCTG 1490